Depression, suicidality, substance-use and associated factors among people living with HIV the COVID-19 pandemic in Uganda.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
29
10
2022
accepted:
19
04
2023
medline:
8
5
2023
pubmed:
5
5
2023
entrez:
5
5
2023
Statut:
epublish
Résumé
Mental disorders are common in people living with HIV (PLHIV) but they are often unrecognized and untreated. Furthermore, the COVID-19 pandemic has disrupted the already limited mental health services in low resource countries such as Uganda, and yet the extent to which the COVID-19 mitigation measures have affected the mental health of PLHIV is not fully known. We aimed to determine the burden of depression, suicidality, substance use and associated factors among adult PLHIV who were seeking care at two HIV clinics in northern and southwestern Uganda. We conducted a phenomenological qualitative and quantitative cross-sectional study among 431 PLHIV to determine the burden of depression, suicidality and substance-use disorders at two HIV clinics, at Lira Regional Referral Hospital and Mbarara Regional Referral Hospital in northern and southwestern Uganda respectively, during the COVID-19 lockdown. We used the Patient Health Questionnaire (PHQ-9) to assess for depression and suicidality, and the Michigan Assessment-Screening Test for Alcohol and drugs (MAST-AD) to assess for substance use disorder. We conducted descriptive statistics analysis to determine the burden of the disorders, and logistic regression to determine the associated factors. For the qualitative method we conducted in-depth interviews with 30 PLHIV and did thematic analysis. Of the 431 PLHIV surveyed, mean age was 40.31 ± 12.20 years; 53.1% (n = 229) had depression; 22.0% (n = 95) had suicidality; and 15.1% (n = 65) had substance-use disorder. Female gender (PR = 1.073, 95%CI 1.004-1.148, P = 0.038), lack of formal education (PR = 1.197, 95% CI 1.057-1.357, P = 0.005), substance-use disorder (PR = 0.924, 95%CI 0.859-0.994, P = 0.034) and suicidality (PR = 0.757, 95%CI 0.722-0.794, p = 0.000) were associated with depression after adjusting for confounders. Further analysis showed that being female (PR = 0.843, 95% CI 0.787-0.903, P = 0.000*) and having depression (PR = 0.927, 95% CI 0.876-0.981, P = 0.009) and owning a large business (PR = 0.886, 95% CI 0.834-0.941, p = 0.000*) were significantly associated with having a substance-use disorder. Only depression was independently associated with suicidality after adjusting for confounding factors (PR 0.108, 95%CI 0.054-0.218, p = 0.000*). For the qualitative results, there were three apriori themes: a) Burden of depression, b) substance-use, and c) suicidality among the PLHIV during the COVID-19 containment measures. There was high prevalence of depression, suicidality and substance-use disorder in adult PLHIV in Uganda during the COVID-19 pandemic and the associated lockdown measures. The three mental health problems seem to have bidirectional relationships and gender has a lot of contribution to the relationships. Interventions aimed at any of the disorders should consider these bidirectional relationships.
Sections du résumé
BACKGROUND
Mental disorders are common in people living with HIV (PLHIV) but they are often unrecognized and untreated. Furthermore, the COVID-19 pandemic has disrupted the already limited mental health services in low resource countries such as Uganda, and yet the extent to which the COVID-19 mitigation measures have affected the mental health of PLHIV is not fully known. We aimed to determine the burden of depression, suicidality, substance use and associated factors among adult PLHIV who were seeking care at two HIV clinics in northern and southwestern Uganda.
METHODS
We conducted a phenomenological qualitative and quantitative cross-sectional study among 431 PLHIV to determine the burden of depression, suicidality and substance-use disorders at two HIV clinics, at Lira Regional Referral Hospital and Mbarara Regional Referral Hospital in northern and southwestern Uganda respectively, during the COVID-19 lockdown. We used the Patient Health Questionnaire (PHQ-9) to assess for depression and suicidality, and the Michigan Assessment-Screening Test for Alcohol and drugs (MAST-AD) to assess for substance use disorder. We conducted descriptive statistics analysis to determine the burden of the disorders, and logistic regression to determine the associated factors. For the qualitative method we conducted in-depth interviews with 30 PLHIV and did thematic analysis.
RESULTS
Of the 431 PLHIV surveyed, mean age was 40.31 ± 12.20 years; 53.1% (n = 229) had depression; 22.0% (n = 95) had suicidality; and 15.1% (n = 65) had substance-use disorder. Female gender (PR = 1.073, 95%CI 1.004-1.148, P = 0.038), lack of formal education (PR = 1.197, 95% CI 1.057-1.357, P = 0.005), substance-use disorder (PR = 0.924, 95%CI 0.859-0.994, P = 0.034) and suicidality (PR = 0.757, 95%CI 0.722-0.794, p = 0.000) were associated with depression after adjusting for confounders. Further analysis showed that being female (PR = 0.843, 95% CI 0.787-0.903, P = 0.000*) and having depression (PR = 0.927, 95% CI 0.876-0.981, P = 0.009) and owning a large business (PR = 0.886, 95% CI 0.834-0.941, p = 0.000*) were significantly associated with having a substance-use disorder. Only depression was independently associated with suicidality after adjusting for confounding factors (PR 0.108, 95%CI 0.054-0.218, p = 0.000*). For the qualitative results, there were three apriori themes: a) Burden of depression, b) substance-use, and c) suicidality among the PLHIV during the COVID-19 containment measures.
CONCLUSION
There was high prevalence of depression, suicidality and substance-use disorder in adult PLHIV in Uganda during the COVID-19 pandemic and the associated lockdown measures. The three mental health problems seem to have bidirectional relationships and gender has a lot of contribution to the relationships. Interventions aimed at any of the disorders should consider these bidirectional relationships.
Identifiants
pubmed: 37146057
doi: 10.1371/journal.pone.0285310
pii: PONE-D-22-29836
pmc: PMC10162553
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0285310Subventions
Organisme : PEPFAR
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010128
Pays : United States
Informations de copyright
Copyright: © 2023 Rukundo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
AIDS Care. 2016 Dec;28(12):1516-1521
pubmed: 27263868
Am J Psychiatry. 1971 Jun;127(12):1653-8
pubmed: 5565851
AIDS Behav. 2017 Nov;21(Suppl 2):204-215
pubmed: 28856539
Int J Soc Psychiatry. 2021 Feb;67(1):54-63
pubmed: 32605422
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):411-7
pubmed: 17099312
AIDS Behav. 2022 Jan;26(1):261-265
pubmed: 34292428
AIDS Behav. 2017 Aug;21(8):2509-2518
pubmed: 28634661
Med Teach. 2020 Aug;42(8):846-854
pubmed: 32356468
Depress Res Treat. 2016;2016:8913160
pubmed: 27747101
Psychiatry Res. 2020 Nov;293:113407
pubmed: 32827993
SAHARA J. 2009 Dec;6(4):155-69
pubmed: 20485855
J Affect Disord. 2017 Apr 01;212:117-127
pubmed: 28160684
AIDS Behav. 2006 Jul;10(4 Suppl):S105-11
pubmed: 16802195
BMC Infect Dis. 2017 Jan 19;17(1):88
pubmed: 28103834
AIDS Behav. 2022 Jul;26(7):2182-2190
pubmed: 34570315
BMC Psychiatry. 2012 Jun 18;12:63
pubmed: 22713589
Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072
pubmed: 27696523
Patient Prefer Adherence. 2022 Aug 20;16:2247-2257
pubmed: 36034331
J Affect Disord. 2013 Jun;148(2-3):188-95
pubmed: 23260381
Am J Addict. 2004 Mar-Apr;13(2):151-62
pubmed: 15204666
Issues Ment Health Nurs. 2021 Mar;42(3):227-238
pubmed: 32783693
J Relig Health. 2020 Oct;59(5):2203-2204
pubmed: 32415426
Afr Health Sci. 2016 Dec;16(4):1027-1035
pubmed: 28479896
PLoS One. 2012;7(12):e49821
pubmed: 23300519
J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):91-97
pubmed: 28084190
AIDS Behav. 2016 Oct;20(10):2408-2417
pubmed: 27150894
Psychosomatics. 1998 Sep-Oct;39(5):405-15
pubmed: 9775697
PLoS One. 2010 Dec 08;5(12):e14252
pubmed: 21170384
BMC Psychiatry. 2011 Dec 30;11:205
pubmed: 22208452
J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S96-100
pubmed: 18089990
J Affect Disord. 2020 Dec 1;277:379-391
pubmed: 32861839
Drug Alcohol Depend. 2013 Jan 1;127(1-3):39-44
pubmed: 22749565
Gen Psychiatr. 2021 Apr 09;34(2):e100247
pubmed: 33912798
Psychiatry Res Commun. 2021 Dec;1(2):
pubmed: 35187539
BMC Infect Dis. 2018 Aug 22;18(1):416
pubmed: 30134851
Clin Infect Dis. 2006 Aug 15;43(4):525-31
pubmed: 16838244
BMC Psychiatry. 2010 Jun 10;10:44
pubmed: 20537129
Global Health. 2020 Sep 25;16(1):90
pubmed: 32977816
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Trop Doct. 2016 Oct;46(4):211-215
pubmed: 26738768
AIDS. 2008 Aug 20;22(13):1651-8
pubmed: 18670226
Curr Opin Psychiatry. 2008 Jan;21(1):14-8
pubmed: 18281835
Alcohol Clin Exp Res. 2020 Oct;44(10):2073-2083
pubmed: 32870516
Can J Psychiatry. 2005 Sep;50(10):660-6
pubmed: 16276858
Clin Ther. 2020 Jun;42(6):962-963
pubmed: 32362345
Glob Ment Health (Camb). 2016 Jun 20;3:e20
pubmed: 28596888
Drug Alcohol Depend. 1983 Nov;12(3):279-85
pubmed: 6653397
Psychiatry Res. 2020 Jul;289:113096
pubmed: 32405115
BJPsych Open. 2020 Oct 19;6(6):e125
pubmed: 33070797
BMC Public Health. 2017 Jun 2;17(1):542
pubmed: 28577548
Acta Psychiatr Scand. 2020 Sep;142(3):249-256
pubmed: 32716520
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
HIV AIDS (Auckl). 2020 Nov 06;12:707-715
pubmed: 33192101
BMC Health Serv Res. 2018 Nov 26;18(1):890
pubmed: 30477492
AIDS Care. 2008 Sep;20(8):917-24
pubmed: 18777220
Afr J Psychiatry (Johannesbg). 2010 Mar;13(1):43-51
pubmed: 20428598
Psychol Trauma. 2020 Oct;12(7):809-811
pubmed: 32853014
BMC Res Notes. 2021 Jul 26;14(1):286
pubmed: 34311785
Suicide Life Threat Behav. 2020 Dec;50(6):1241-1249
pubmed: 32589799
BMC Public Health. 2021 Mar 8;21(1):467
pubmed: 33685420
Syst Rev. 2018 Nov 28;7(1):211
pubmed: 30486900
AIDS Res Treat. 2016;2016:3015468
pubmed: 27073694
Australas Psychiatry. 2020 Oct;28(5):524-526
pubmed: 32722961
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
BMC Public Health. 2020 Oct 23;20(1):1598
pubmed: 33097028
Asian J Psychiatr. 2020 Jun;51:102076
pubmed: 32334409
J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S179-87
pubmed: 25436816
Arch Suicide Res. 2015;19(1):103-16
pubmed: 25058473
Soc Sci Med. 2008 Mar;66(6):1334-45
pubmed: 18234406
J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):23-35
pubmed: 24899261
Aust N Z J Psychiatry. 2021 Mar;55(3):324
pubmed: 32900218
J Affect Disord. 2020 Sep 1;274:1-7
pubmed: 32405111
Clin Psychol Rev. 2000 Mar;20(2):173-89
pubmed: 10721496
Sex Transm Dis. 2007 Nov;34(11):856-63
pubmed: 18049422
J Stud Alcohol Drugs. 2021 Jul;82(4):486-492
pubmed: 34343080
Curr Pharm Teach Learn. 2018 Jun;10(6):807-815
pubmed: 30025784
Med Sci Monit. 2020 Apr 26;26:e924609
pubmed: 32335579